ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma receives warning letter from USFDA for Telangana plant
Natco Pharma on Tuesday said it has received a warning letter from the US health regulator for its Telangana-based manufacturing plant. The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company's
Announcement as on 09 April 2024

Natco Pharma gets warning letter from USFDA for Telangana plant
Natco Pharma, a pharmaceutical company, received a warning letter from the USFDA regarding its manufacturing plant in Telangana. This came after the FDA conducted an inspection of the company's facility in Kothur last October, issuing eight observations un
Announcement as on 09 April 2024

Accumulate NATCO Pharma; target of Rs 1116: Geojit Financial Services
Geojit Financial Services recommended accumulate rating on NATCO Pharma with a target price of Rs 1116 in its research report dated March 27, 2024.
Announcement as on 27 March 2024

Delhi HC bars Natco Pharma from selling cancer drug Olaparib
The Delhi High Court has prohibited Natco Pharma from producing and selling the cancer drug Olaparib, marketed as 'BRACANAT' or under any other name, until further notice. The court's decision came in response to a lawsuit by Kudos Pharmaceuticals, which c
Announcement as on 04 March 2024

Natco Pharma Q3 net profit rises over 3-fold to Rs 212.7 crore
The company had posted a consolidated net profit of Rs 62.3 crore in the same period last fiscal, Natco Pharma said in a regulatory filing.
Announcement as on 14 February 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 904.17
  • 12Day Average: 912.84
  • 20Day Average: 912.76
  • 50Day Average: 868.65
  • 100Day Average: 863.19
  • 150Day Average: 886.3
  • 200Day Average: 871.14

524816 Indicators & signals

Indicator MACD (12,26,9)

907.76, 898.75, 13.82
Indicator MACD is in positive zone

Indicator ADX (14)

9.76, 24.41, 20.06
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
31 Wed Dec 2025 903.55 898.55 to 908.00 0.72% 0.25 times
30 Tue Dec 2025 897.05 887.55 to 908.25 0.13% 0.94 times
29 Mon Dec 2025 895.90 894.20 to 911.30 -1.34% 0.51 times
26 Fri Dec 2025 908.10 905.70 to 920.00 -0.89% 0.86 times
24 Wed Dec 2025 916.25 911.50 to 926.70 -1.18% 1.07 times
23 Tue Dec 2025 927.15 922.50 to 950.40 0.38% 0.64 times
22 Mon Dec 2025 923.65 910.90 to 927.00 0.63% 1.12 times
19 Fri Dec 2025 917.90 913.10 to 943.00 0.33% 1.35 times
18 Thu Dec 2025 914.85 910.95 to 924.35 -0.83% 1.03 times
17 Wed Dec 2025 922.50 913.05 to 929.40 0.05% 1.18 times
16 Tue Dec 2025 922.05 904.45 to 928.00 1.87% 1.3 times
15 Mon Dec 2025 905.10 895.55 to 918.00 -0.11% 1.22 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top